Mdxhealth to Release First Quarter 2025 Financial Results on May 14
MDxHealth, a precision diagnostics company listed on NASDAQ (MDXH), has scheduled the release of its first quarter 2025 financial results for May 14, 2025, after market close. The company will host a conference call and webcast at 4:30pm ET / 22:30 CET on the same day.
CEO Michael K. McGarrity and CFO Ron Kalfus will lead the presentation. Investors can join via multiple regional dial-in numbers:
- United States: 1-844-825-9789
- Belgium: 0800 38 961
- Netherlands: 0800 94 94 506
- United Kingdom: 0808 238 9064
Participants should access the webcast 15 minutes before the start time using Conference ID 10199102. A replay will be available on the company's website after the live call.
MDxHealth, una società di diagnostica di precisione quotata al NASDAQ (MDXH), ha programmato la pubblicazione dei risultati finanziari del primo trimestre 2025 per il 14 maggio 2025, dopo la chiusura dei mercati. La società terrà una conference call e una webcast alle 16:30 ET / 22:30 CET dello stesso giorno.
Il CEO Michael K. McGarrity e il CFO Ron Kalfus guideranno la presentazione. Gli investitori potranno partecipare tramite diversi numeri di telefono regionali:
- Stati Uniti: 1-844-825-9789
- Belgio: 0800 38 961
- Paesi Bassi: 0800 94 94 506
- Regno Unito: 0808 238 9064
I partecipanti dovrebbero accedere alla webcast 15 minuti prima dell’inizio utilizzando il Conference ID 10199102. Una registrazione sarà disponibile sul sito web della società dopo la chiamata in diretta.
MDxHealth, una empresa de diagnóstico de precisión cotizada en el NASDAQ (MDXH), ha programado la publicación de sus resultados financieros del primer trimestre de 2025 para el 14 de mayo de 2025, después del cierre del mercado. La empresa realizará una conferencia telefónica y una transmisión en vivo a las 4:30 pm ET / 22:30 CET el mismo día.
El CEO Michael K. McGarrity y el CFO Ron Kalfus dirigirán la presentación. Los inversores pueden unirse mediante varios números regionales:
- Estados Unidos: 1-844-825-9789
- Bélgica: 0800 38 961
- Países Bajos: 0800 94 94 506
- Reino Unido: 0808 238 9064
Los participantes deben acceder a la transmisión en vivo 15 minutos antes del inicio utilizando el ID de conferencia 10199102. Una grabación estará disponible en el sitio web de la empresa después de la llamada en vivo.
MDxHealth는 NASDAQ (MDXH)에 상장된 정밀 진단 회사로, 2025년 1분기 재무 결과를 2025년 5월 14일 장 마감 후에 발표할 예정입니다. 같은 날 오후 4시 30분 ET / 22시 30분 CET에 컨퍼런스 콜 및 웹캐스트가 진행됩니다.
CEO Michael K. McGarrity와 CFO Ron Kalfus가 발표를 진행합니다. 투자자들은 여러 지역별 전화번호를 통해 참여할 수 있습니다:
- 미국: 1-844-825-9789
- 벨기에: 0800 38 961
- 네덜란드: 0800 94 94 506
- 영국: 0808 238 9064
참가자는 시작 15분 전에 컨퍼런스 ID 10199102를 사용하여 웹캐스트에 접속해야 합니다. 생중계 후 회사 웹사이트에서 다시보기 영상을 이용할 수 있습니다.
MDxHealth, une société de diagnostics de précision cotée au NASDAQ (MDXH), a programmé la publication de ses résultats financiers du premier trimestre 2025 pour le 14 mai 2025, après la clôture des marchés. La société organisera une conférence téléphonique et une webdiffusion à 16h30 ET / 22h30 CET le même jour.
Le PDG Michael K. McGarrity et le CFO Ron Kalfus animeront la présentation. Les investisseurs peuvent participer via plusieurs numéros d’appel régionaux :
- États-Unis : 1-844-825-9789
- Belgique : 0800 38 961
- Pays-Bas : 0800 94 94 506
- Royaume-Uni : 0808 238 9064
Les participants doivent accéder à la webdiffusion 15 minutes avant le début en utilisant l’ID de conférence 10199102. Une rediffusion sera disponible sur le site web de la société après l’appel en direct.
MDxHealth, ein auf Präzisionsdiagnostik spezialisiertes Unternehmen, das an der NASDAQ (MDXH) gelistet ist, hat die Veröffentlichung seiner Finanzergebnisse für das erste Quartal 2025 für den 14. Mai 2025 nach Börsenschluss geplant. Am selben Tag findet um 16:30 Uhr ET / 22:30 Uhr MEZ eine Telefonkonferenz und ein Webcast statt.
CEO Michael K. McGarrity und CFO Ron Kalfus werden die Präsentation leiten. Investoren können über verschiedene regionale Einwahlnummern teilnehmen:
- USA: 1-844-825-9789
- Belgien: 0800 38 961
- Niederlande: 0800 94 94 506
- Vereinigtes Königreich: 0808 238 9064
Teilnehmer sollten sich 15 Minuten vor Beginn mit der Konferenz-ID 10199102 in den Webcast einwählen. Eine Aufzeichnung wird nach dem Live-Call auf der Website des Unternehmens verfügbar sein.
- None.
- None.
Company to Host Conference Call with Live Q&A, May 14, 2025, at 4:30pm ET / 22:30 CET
IRVINE, California – April 30, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended March 31, 2025, after market close on Wednesday, May 14, 2025.
| Title: | Mdxhealth Presents First Quarter 2025 Financial Results and Corporate Update Conference Call and Webcast |
| Speakers: | Michael K. McGarrity, Chief Executive Officer Ron Kalfus, Chief Financial Officer |
| Date: | May 14, 2025 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-844-825-9789 Belgium: 0800 38 961 The Netherlands: 0800 94 94 506 United Kingdom: 0808 238 9064 |
| Conference ID: | 10199102 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1716341&tp_key=092e4b795e |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
| MDxHealth info@mdxhealth.com | |
| LifeSci Advisors (IR & PR) US: +1 949 271 9223 ir@mdxhealth.com |
FAQ
When will MDxHealth (MDXH) release Q1 2025 financial results?
How can investors join MDxHealth's Q1 2025 earnings call?
What is the conference ID for MDXH's Q1 2025 earnings call?
Will there be a replay available for MDxHealth's Q1 2025 earnings call?
What time does MDXH's Q1 2025 earnings call start in European time?
